The bill aims to regulate manufacturing, labeling, and sale of cannabinoid products, prevent underage cannabis use, and address cannabis-impaired driving. It mandates registration and compliance requirements for facilities, safety standards, and labeling regulations. The bill also emphasizes the FDA's authority over cannabinoid products and establishes provisions for safety assessment, recall of unsafe products, and prohibition of flavored electronic cannabinoid delivery systems. It clarifies federal, state, and tribal enforcement of laws and instructs the Secretary to develop prevention campaigns and national standards for cannabis-impaired driving. A grant program is established to help states prevent cannabis-impaired driving, focusing on enforcement, data collection, and education. The bill proposes additional funding for surveillance and research programs and defines terms related to cannabis and THC.